Pubblicazioni

Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without Radium 223

2021 - CANCER BIOTHERAPY & RADIOPHARMACEUTICALS

Caffo, Orazio; Frantellizzi, Viviana; Monari, Fabio; Galli, Luca; Costa, Renato Patrizio; Pinto, Carmine; Tucci, Marcello; Baldari, Sergio; Facchini, Gaetano; Bortolus, Roberto; Alongi, Filippo; Alongi, Pierpaolo; Donner, Davide; Fanti, Stefano; Sbrana, Andrea; Morabito, Alessandra; Masini, Cristina; Zichi, Clizia; Pignata, Salvatore; Borsatti, Eugenio; Salgarello, Matteo; Spada, Massimiliano; De Giorgi, Ugo; Lo Re, Giovanni; Cortesi, Enrico; De Vincentis, Giuseppe

Prognostic Factors in De Novo Metastatic Renal Cell Carcinoma: A Report From the Latin American Renal Cancer Group

2021 - JCO GLOBAL ONCOLOGY

Abreu, Diego; Carvalhal, Gustavo; Gueglio, Guillermo; Tobia, Ignacio; Garcia, Patricio; ZuÃ±iga, Alvaro; Meza, Luis; BengiÃ³, RubÃ©n; Scorticati, Carlos; Castillejos, Ricardo; Rodriguez, Francisco; Autran, Ana MarÃa; Gonzales, Carmen; Gadu, Jose; Nolazco, Alejandro; Ameri, Carlos; Zampolli, Hamilton; Langenhin, RaÃºl; Muguruza, Diego; Machado, Marcos TobÃas; Mingote, Pablo; Yandian, Juan; Clavijo, Jorge; Nogueira, Lucas; Clark, Omar; Secin, Fernando; Rovegno, AgustÃn; Vilas, Ana; Barrios, Enrique; Decia, Ricardo; GuimarÃ£es, Gustavo; Glina, Sidney; Pal, Sumanta K; Rodriguez, Oscar; Palou, Joan; Spiess, Philippe; Lara, Primo N; Linehan, W Marston; Pastore, Antonio Luigi; Zequi, Stenio C

A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from mature overall survival data

2021 - FRONTIERS IN ONCOLOGY

Maggi, Martina; Salciccia, Stefano; Del Giudice, Francesco; Busetto, Gian Maria; Falagario, Ugo G; Carrieri, Giuseppe; Ferro, Matteo; Porreca, Angelo; Di Pierro, Giovanni Battista; Fasulo, Vittorio; Frantellizzi, Viviana; De Vincentis, Giuseppe; De Berardinis, Ettore; Sciarra, Alessandro

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients

2021 - FRONTIERS IN ONCOLOGY

Hoeh, B.; Wurnschimmel, C.; Flammia, R. S.; Horlemann, B.; Sorce, G.; Chierigo, F.; Tian, Z.; Saad, F.; Graefen, M.; Gallucci, M.; Briganti, A.; Terrone, C.; Shariat, S. F.; Tilki, D.; Kluth, L. A.; Mandel, P.; Chun, F. K. H.; Karakiewicz, P. I.

Computed tomography based radiomics as a predictor of survival in ovarian cancer patients: a systematic review

2021 - CANCERS

Rizzo, Stefania; Manganaro, Lucia; Dolciami, Miriam; Gasparri, MARIA LUISA; Papadia, Andrea; Del Grande, Filippo

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Lawless, S; Sbianchi, G; Morris, C; Iacobelli, S; Bosman, P; Blaise, D; Remenyi, P; Byrne, Jl; Mayer, J; Apperley, J; Lund, J; Kobbe, G; Schaap, N; Isaksson, C; Lenhoff, S; Basak, G; Touzeau, C; Wilson, Kmo; Muniz, Sg; Scheid, C; Browne, P; Anagnostopoulos, A; Rambaldi, A; Jantunen, E; Kroger, N; Schonland, S; Yakoub-Agha, I; Garderet, L